July 27, 2012 — Virginia Hospital Center is among the few hospitals along the east coast to offer the new Calypso System featuring GPS for the Body technology and Beacon electromagnetic transponders for patients with certain types of cancer. This new technology provides accurate, precise and real-time tracking to keep radiation focused on the tumor resulting in fewer side effects and a better quality of life for the patient.

July 27, 2012 — With a great deal of practical, clinical feedback from a broad demographic of facilities with differing processes and needs, ScImage has comprehensively improved the workflow and the consequent efficiency of its PicomSRI structured reporting platform.

July 27, 2012 — MedidaMetrics Inc. announced a multifaceted agreement with Mayo Clinic, making Mayo’s radiology CareMaps available to other medical providers and conducting an ExactCost pilot in the radiology department. The agreement includes equity in MedidaMetrics for Mayo Clinic.

July 27, 2012 — International medical technology company Sectra will demonstrate its web-based, multi-modality breast imaging picture archive and communications system (PACS), featuring the ability to read breast tomosynthesis, at booth 221 at the 40th Annual Association for Medical Imaging Management held August 12 to 15 in Orlando, Fla.

July 27, 2012 — The Journal of Ultrasound in Medicine has published a pilot study conducted at Thomas Jefferson University in Philadelphia, with funding provided by Toshiba, that explores the effectiveness of Toshiba America Medical Systems Inc.’s MicroPure image processing technique in visualizing breast microcalcifications compared with grayscale ultrasound imaging.

July 27, 2012 — Accuray Inc. announced the extension of its Emerald Service Program for the TomoTherapy system, which provides equipment protection and product updates that improve clinical uptime and enhance technology utilization, to customers throughout Japan.

A study using CT perfusion imaging showed patients presenting with ischemic stroke may be successfully treated with endovascular or minimally invasive therapy well beyond the eight-hour treatment window considered standard by most neurointerventional practitioners.